Note to editors: Silicon Laboratories, Silicon Labs, the "S" symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.
CONTACT: Jalene Hoover, +1 (512) 428-1610, Jalene.Hoover@silabs.com
|
Silicon Laboratories Inc. | |||
|
Condensed Consolidated Statements of Income | |||
|
(In thousands, except per share data) | |||
|
(Unaudited) | |||
|
| |||
|
|
Three Months Ended | ||
|
|
March 31,
|
|
April 1,
|
|
Revenues |
$205,384 |
|
$179,028 |
|
Cost of revenues |
81,147 |
|
73,867 |
|
Gross margin |
124,237 |
|
105,161 |
|
Operating expenses: |
|
|
|
|
Research and development |
54,828 |
|
52,324 |
|
Selling, general and administrative |
45,694 |
|
40,155 |
|
Operating expenses |
100,522 |
|
92,479 |
|
Operating income |
23,715 |
|
12,682 |
|
Other income (expense): |
|
|
|
|
Interest income and other, net |
3,202 |
|
576 |
|
Interest expense |
(4,883) |
|
198 |
|
Income before income taxes |
22,034 |
|
13,456 |
|
Provision (benefit) for income taxes |
(4,371) |
|
(1,970) |
|
Net income |
$ 26,405 |
|
$ 15,426 |
|
|
|
|
|
|
Earnings per share: |
|
|
|
|
Basic |
$ 0.61 |
|
$ 0.37 |
|
Diluted |
$ 0.60 |
|
$ 0.36 |
|
|
|
|
|
|
Weighted-average common shares outstanding: |
|
|
|
|
Basic |
42,963 |
|
42,096 |
|
Diluted |
43,918 |
|
43,030 |
|
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures | ||||||||||||||||||||||||||||||||
|
(In thousands, except per share data) | ||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||
|
Non-GAAP Income
|
|
Three Months Ended March 31, 2018 |
|
|
| |||||||||||||||||||||||||||
|
|
|
GAAP
|
|
GAAP Percent of
|
|
Stock
|
|
Intangible
|
|
Acquisition
|
|
Non-GAAP
|
|
Non-GAAP
|
|
|
| |||||||||||||||
|
Revenues |
|
$205,384 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
|
Gross margin |
|
124,237 |
|
60.5% |
|
$ 296 |
|
$ -- |
|
$ -- |
|
$124,533 |
|
60.6% |
|
|
| |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
|
Research and development |
|
54,828 |
|
26.7% |
|
5,769 |
|
4,787 |
|
-- |
|
44,272 |
|
21.6% |
|
|
| |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
|
Selling, general and administrative |
|
45,694 |
|
22.3% |
|
6,127 |
|
1,515 |
|
700 |
|
37,352 |
|
18.1% |
|
|
| |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
|
Operating income |
|
23,715 |
|
11.5% |
|
12,192 |
|
6,302 |
|
700 |
|
42,909 |
|
20.9% |
|
|
| |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
